Immunological Criteria of Autoaggression of Bronchial Asthma: Markers for Prediction of the Course and Selection of Adequate Pharmacotherapy
DOI:
https://doi.org/10.53933/sspmpm.v3i1.84Keywords:
bronchial asthma, immunological status, hormone dependence, autoaggression, prognostic markers, pharmacotherapy, drugsAbstract
About 10% of the population of highly developed European countries suffer from bronchial asthma. Monitoring for the period 2014-2021 regarding the number of patients with bronchial asthma in the Lviv region showed an increase in dynamics. The prevalence of bronchial asthma among the population is much higher, because patients do not always consult an allergist, but are treated by other specialists. This is a serious problem today, as blood pressure reduces the quality of life and work capacity of patients. Against the background of the increasing incidence of bronchial asthma, the frequency of the severe course of this disease is also increasing, which takes on the character of autoaggression and requires the use of increasing doses of glucocorticoids during treatment, up to daily replacement therapy. Accordingly, it is important to establish the immunological criteria of autoaggression in blood pressureas markers for predicting the severity of the course and choosing an adequate drug treatment.
References
Asthma. WHO. 11.05.2022. URL: https://www.who.int/news-room/fact-sheets/detail/asthma.
Kavanagh J., Jackson D.J., Kent B.D. Over- and under-diagnosis in asthma. Breathe. 2019. Vol. 15: No. 1. P. 20-27. URL: https://breathe.ersjournals.com/content/15/1/e20 DOI: https://doi.org/10.1183/20734735.0362-2018
Finland: EU country with highest share of asthmatics. Eurostat. 24.09.2021. URL: https://ec.europa.eu/eurostat/web/products-eurostat-news/-/edn-20210924-1.
Svezhentseva I. Day of patients with bronchial asthma. What everyone should know. Suspilne.Media. 11.12.2021. URL: https://suspilne.media/188425-den-hvorih-na-bronhialnu-astmu-so-varto-znati-koznomu/.
Kushinska I., Nevzhoda A. If the temperature suddenly drops from high to below 36, then, as a rule, on the second or third day - pneumonia. WZ.Lviv.Ua. 25.03.2020. URL: https://wz.lviv.ua/life/409096-anatolii-nevzhoda-yakshcho-temperatura-z-pidvyshchenoi-rizko-padaie-do-nyzhche-36-to-iak-pravylo-na-druhyi-tretii-den-pnevmoniia.
Half a glass three times a day: Lviv doctors received a patent for the treatment of coronavirus. Vgorode. 09.11.2020. URL: https://lviv.vgorode.ua/news/sobytyia/a1139216-po-piv-charki-trichi-na-den-lvivski-likari-otrimali-patent-na-likuvannja-koronavirusu.
In Lviv, they patented their method of treating coronavirus pneumonia. 4studio. 31.01.2021. URL: https://4studio.com.ua/novyny/u-lvovi-zapatentuvaly-svij-metod-likuvannya-koronavirusnoyi-pnevmoniyi-video/.
Lviv doctors received a patent for the treatment of coronavirus with alcohol. Ukrainian reporter. 08.02.2021. URL: https://ukrreporter.com.ua/suspilstvo/lvivski-likari-otrymaly-patent-na-likuvannya-koronavirusu-spytrom.html.
Lviv medical brothers patented a new method of treating COVID-19 with alcohol. LMN. 01.02.2021. URL: https://www.lmn.in.ua/lvivski-braty-medyky-zapatentuvaly-novyj-metod-likuvannia-covid-19-spyrtom/.
Kushinska I., Nevzhoda A. If the temperature is high and suddenly drops below 36 degrees, this indicates that there may be pneumonia. Interview from Ukraine. 06.08.2020. URL: https://rozmova.wordpress.com/2020/08/13/anatoliy-nevzhoda/.
Salvi S.S., Barnes P.J. Chronic obstructive pulmonary disease in non-smokers. The Lancet. 2009. Vol. 374. Iss. 9691. Р. 733-743. DOI: https://doi.org/10.1016/s0140-6736(09)61303-9. DOI: https://doi.org/10.1016/S0140-6736(09)61303-9
Kim D.S., Kim Y.S., Jung K.-S. et al. Prevalence of chronic obstructive pulmonary disease in Korea: a population-based spirometry survey. Am. J. Respir. Crit. Care. Med. 2005. No. 172(7). Р. 842-847. DOI: https://doi.org/10.1164/rccm.200502-259OC. DOI: https://doi.org/10.1164/rccm.200502-259OC
Zhou Y, Wang C, Yao W. et al. COPD in Chinese nonsmokers. Eur Respir J. 2009. No. 33(3). P. 509–518. DOI: https://doi.org/10.1183/09031936.00084408. DOI: https://doi.org/10.1183/09031936.00084408
Ehrlich R.I., White N., Norman R. et al. Predictors of chronic bronchitis in South African adults. Int. J. Tuberc. Lung. Dis. 2004. No. 8(3). Р. 369-376.
Forbes L., Kapetanakis V, Rudnicka A. et al. Chronic exposure to outdoor air pollution and lung function in adults. Thorax. 2009. No. 64(8). P. 657-663. DOI: https://doi.org/10.1136/thx.2008.109389
Hopkinson N.S., Polkey M.I. Chronic obstructive pulmonary disease in non-smokers. The Lancet. 2015. No. 374 (9706). P. 1964. DOI: https://doi.org/10.1016/S0140-6736(09)62115-2
Hopkinson N.S., Molyneux A., Pink J. et al. Chronic obstructive pulmonary disease: diagnosis and management: summary of updated NICE guidance. BMJ. 2019. No. 366. P. 4486 DOI: https://doi.org/10.1136/bmj.l4486
Doust E., Ayres J., Devereux G. et al. Is pesticide exposure a cause of obstructive airways disease? Eur. Respir. Rev. 2014. No. 23(132). P. 180-192. DOI: https://doi.org/10.1183/09059180.00005113
Arroyave M.E. Pulmonary obstructive disease in a population using paraquat in Colombia. World Environmental Library.1993. P. 1-7.
Lamprecht B., Schirnhofer L., Kaiser B. et al. Farming and the prevalence of non-reversible airways obstruction – results from a population-based study. Am. J. Ind. Med. 2007. No. 50(6). P. 421-426. DOI: https://doi.org/10.1002/ajim.20470
De Jong K., Boezen H.M., Kromhout H. et al. Original contribution association of occupational pesticide exposure with accelerated longitudinal decline in lung function. Am. J. Epidemiol. 2014. No. 179 (11). P. 1323-1330. DOI: https://doi.org/10.1093/aje/kwu053
Kemp J.P. Recent advances in the management of asthma using leukotriene modifiers. Am. J. Respir. Med. 2003. No 2(2). P. 139-56. URL: https://pubmed.ncbi.nlm.nih.gov/14720013/. DOI: https://doi.org/10.1007/BF03256645
Gracia M С. A possible cause and corresponding treatment for inflammatory, auto-immune or auto-aggressive diseases. Med Hypotheses. 2007. No. 69(2). Р. 395-402. URL: https://pubmed.ncbi.nlm.nih.gov/17320308/. DOI: https://doi.org/10.1016/j.mehy.2006.12.030
Zerbino D.D. General pathology of the lymphatic system. Kyiv. Zdorovye. 1974. 170 p.
Zerbino D.D. Modern pathology of the aorta: classification and main diseases. Practical angiology. 2010. No. 3. P. 18-23.
Ryabukha О. COVID-19: Multidisciplinary studies on the thyroid activity during the pandemic and post-covid processes. Actual Problems of Medicine and Pharmacy. 2022. Vol. 3. No. 1. P.1-25. URL: https://doi.org/10.52914/apmp.v3i1.39. DOI: https://doi.org/10.52914/apmp.v3i1.39
Hayduchok I.G., Shapovalova V.O., Ishcheikin K.E., Chopyak V.V., Shapovalov V.V. Pharmacoeconomic approaches for pharmacotherapy of rheumatoid arthritis. Likars'ka sprava. 2021. Iss.1-2. P.70-79. URL: https://liksprava.com/index.php/journal/article/view/463. DOI: https://doi.org/10.31640/JVD.1-2.2021(11)
Shapovalova V. Forensic and pharmaceutical risks in the organization of pharmacotherapy of covid, post-covid and long-covid disorders. COVID-19 and vaccination practice standards. SSP Modern Pharmacy and Medicine. 2022. Vol. 2. No. 4. P.1–24. URL: https://doi.org/10.53933/sspmpm.v2i4.69. DOI: https://doi.org/10.53933/sspmpm.v2i4.69
Gudzenko A., Shapovalov V., Shapovalov V. et al. Forensic pharmacy: analysis of complaints about the pharmaceutical provision for privileged categories of patients in Ukraine (experimental research). Science Review. 2021. V. 2. Iss. 37. P. 1–6. URL: https://rsglobal.pl/index.php/sr/article/view/1965.
Shapovalov Valentyn V., Gudzenko A.O., Shapovalova V.O. et al. Clinical and pharmacological, classification and legal, nomenclature and legal distribution of medicines for pharmacotherapy of depression among combatants (F 32-33). Health of Society. 2021. Vol. 7. No. 4. Р. 181-186. URL: https://health-society.zaslavsky.com.ua/index.php/journal/article/view/168.
Hayduchok I.G., Shapovalova V.O., Shapovalov V.V. et al. Drug control regime for the pharmacotherapy of the coronavirus disease (COVID-19) in patients with systemic diseases. Information letter about innovations in the field of health care. 2020. No. 225. 8 p. URL: https://medinstytut.lviv.ua/wp-content/uploads/pdf/Informatsiynyy-lyst.pdf.
Hayduchok I., Shapovalov V. Forensic pharmacy and medicine: risks for pharmacotherapy of addiction and countering of illegal circulation of psychoactive substances in the COVID-19 pandemic. 2021. SSP Modern Pharmacy and Medicine. Vol. 1. N. 2. P.1-28. https://doi.org/10.53933/sspmpm.v1i2.32. DOI: https://doi.org/10.53933/sspmpm.v1i2.32
Shapovalov V. (Jr.), Zbrozhek S., Gudzenko A., Shapovalova V. et al. Organizational and legal analysis of the pharmaceutical provision for the most common diseases of society. International Journal of Pharmaceutical Sciences Review and Research. 2018. Vol. 51. Nо. 1. P. 118-124. URL: http://globalresearchonline.net/journalcontents/v51-1/18.pdf.
Last year, more than 9,000 patients with bronchial asthma were registered in the Lviv region. Varianty. 29.05.2015. URL: https://varianty.lviv.ua/26530-mynuloho-roku-na-lvivshchyni-zafiksuvaly-bilshe-9-tys-khvorykh-na-bronkhialnu-astmu.
December 11 is World Asthma Day. Communal Healthcare Institution "Lviv Regional Information and Analytical Center of Medical Statistics". 11.12.2021. URL: https://lvivphc.org.ua/event/asthma_day_2021.
December 11 – World Asthma Day. Communal Healthcare Institution "Lviv Regional Information and Analytical Center of Medical Statistics". 11.12.2022. URL: https://lvivphc.org.ua/event/asthma_day_2022.
Bronchial asthma in winter: relief or exacerbation. Dila.ua 15.01.2021. URL: https://dila.ua/news/ba_zymoyu_150121.html.
Shapovalova V.A., Zbrozhek S.I., Shapоvalov V.V. et al. Coronavirus disease pandemia 2019: growth of epidemic dangers. Acta scientific pharmaceutical sciences. 2020. Vol. 4. Iss. 7. P. 61–68. URL: https://www.actascientific.com/ASPS/ASPS-04-0559.php. DOI: https://doi.org/10.31080/ASPS.2020.04.0559
Shapovalova V. An Innovative multidisciplinary study of the availability of coronavirus vaccines in the world. SSP Modern Pharmacy and Medicine. 2022. Vol.2. Nо.2. P.1–17 URL: https://doi.org/10.53933/sspmpm.v2i2.45. DOI: https://doi.org/10.53933/sspmpm.v2i2.45
Shapovalova V. Monkeypox virus – new challenges of modernity: experimental organizational and legal, clinical and pharmacological studies. SSP Modern Pharmacy and Medicine. 2022. Vol.2. Nо.3. P.1–15. URL: https://doi.org/10.53933/sspmpm.v2i3.54. DOI: https://doi.org/10.53933/sspmpm.v2i3.54
Shapovalova V., Shapovalov V., Shapovalov Valentyn et al. The COVID-19 pandemic (strains "Delta", "Omicron"): particularities of study on the thematic cycle "General Pharmacy based on pharmaceutical law". Actual problems of medicine and pharmacy. 2022. Vol.3. Nо.1. Р.1–18. URL: https://doi.org/10.52914/apmp.v3i1.36. DOI: https://doi.org/10.52914/apmp.v3i1.36
Shapovalova V. The ICD-11 for the twenty-first century: the first view from the organizational, legal, clinical and pharmacological aspects. SSP Modern Pharmacy and Medicine. 2022. Vol.2. Nо.1. P.1-13. URL: https://doi.org/10.53933/sspmpm.v2i1.37. DOI: https://doi.org/10.53933/sspmpm.v2i1.37
Ivanishyn-Hayduchok L., Shapovalova V., Shapovalov V. ICD-11: Organizational and legal, medical and pharmaceutical, social and economic issues of implementation of the program of state guarantees of medical care in 2022 in Ukraine, based on the fundamental principles of the European Union. SSP Modern Pharmacy and Medicine. 2022. Vol.2. Nо.2. Р.1–14. URL: https://doi.org/10.53933/sspmpm.v2i2.53. DOI: https://doi.org/10.53933/sspmpm.v2i2.53
Shapovalov V.V. (Jr.), Shapovalova V.A., Shapovalov V.V. Development of forensic and pharmaceutical researches within the organization of pharmaceutical business, drug technology and pharmaceutical law in Ukraine concerning the turnover of controlled drugs and substances. Health of Society. 2021. Vol.10. Nо.3. P.98-106. URL: https://doi.org/10.22141/2306-2436.10.3.2021.246351. DOI: https://doi.org/10.22141/2306-2436.10.3.2021.246351
Shapovalov V. (Jr.), Gudzenko A., Shapovalova V. еt аl. Forensic and pharmaceutical study of the presence of a causal link between the degree of alcohol abuse and qualification level of the respondents. Pharmacia. 2017. Vol.66. Nо.3. Р. 31–39. URL: http://bsphs.org/wp-content/uploads/2017/11/Shapovalov.pdf.
Chuiev Y., Shapovalova V. Integrated ABC/VEN-analysis of drug prescriptions in pharmacotherapeutic schemes for relief of drunken forms of alcohol dependence. SSP Modern Pharmacy and Medicine. 2022. Vol.2. Nо.1. P.1-14. URL: https://doi.org/10.53933/sspmpm.v2i1.35. DOI: https://doi.org/10.53933/sspmpm.v2i1.35
Shapovalova V. Alcoholic Hepatitis: An Experimental Meta-Analysis. SSP Modern Pharmacy and Medicine. 2023. Vol.3. No.1. P.1-11. doi: https://doi.org/10.53933/sspmpm.v3i1.77. URL: https://doi.org/10.53933/sspmpm.v3i1.77. DOI: https://doi.org/10.53933/sspmpm.v3i1.77
Ryabukha O. COVID-19 Pandemic encourages to deepen the study of the thyroid gland: correlation portraits as a means of research in different directions of follicular thyrocytes activities. SSP Modern Pharmacy and Medicine. 2022. Vol.2. No.1. P.1-21. URL: https://doi.org/10.53933/sspmpm.v2i1.40. DOI: https://doi.org/10.53933/sspmpm.v2i1.40
Shapovalova V.A., Voloshyn P.V., Stefanov A.V. et al. Medicines for neurologists, psychiatrists and narcologists. Kh.: Fakt. 2003. 784 p.
Shapovalova V.A., Sosyn I.K., Butenko G.M. et al. Pharmaceutical law in narcology. Kharkov: "Fact". 2004. 800 p.
Gubskyi Y.I., Shapovalova V.O., Kutko I.I. et al. Medicines in psychopharmacology. K.: "Health", Kharkiv: "Torsing".1997. 288 p.
Sosin I.K., Chuev Yu.F., Artemchuk A.P., Shapovalova V.O. et al. Narcology: national textbook. Kharkiv, Ukraine: Kolegium. 2014. 948 p.
Shapovalov V.V., Shapovalova V.O., Bondarenko V.V. Evidential pharmacy regarding the forensic support of modified substances removed from illegal circulation as a measure to combat the spread of drug addiction. Zaporozhye medical journal. 2007. No. 3. P. 175-177.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Anatoly Nevzhoda
This work is licensed under a Creative Commons Attribution 4.0 International License.
